CN Patent

CN120398908A — Pde4b抑制剂及其药物组合物和用途

Assigned to Apex Biotechnology Corp · Expires 2025-08-01 · 1y expired

What this patent protects

本公开提供具有优异PDE4B抑制活性的式H化合物及其药物组合物和用途。本公开提供的化合物可用于有效治疗PDE4相关的疾病和病症，包括但不限于呼吸道炎性疾病、炎性肠病、关节炎性疾病、皮肤炎性疾病，眼睛炎性疾病以及外周或中枢神经系统的疾病或癌症。

USPTO Abstract

本公开提供具有优异PDE4B抑制活性的式H化合物及其药物组合物和用途。本公开提供的化合物可用于有效治疗PDE4相关的疾病和病症，包括但不限于呼吸道炎性疾病、炎性肠病、关节炎性疾病、皮肤炎性疾病，眼睛炎性疾病以及外周或中枢神经系统的疾病或癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN120398908A
Jurisdiction
CN
Classification
—
Expires
2025-08-01
Drug substance claim
No
Drug product claim
No
Assignee
Apex Biotechnology Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.